HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The long term effects of repeated diethylcarbamazine administration with special reference to microfilaraemia and elephantiasis.

Abstract
The result of mass treatment with 50 mg diethylcarbamazine (DEC) per kg body weight followed by two annual selective retreatments in an area highly endemic for Brugia timori infections are described. The criteria for selective re-treatment are simple and practical for use in rural areas. An education programme was developed which focused on describing the relationship between adenolymphangitis and filarial infections, the danger of repeated attacks and the efficiency of DEC in eliminating these attacks. Motivated persons in the community were charged with the responsibility of promptly treating all cases with acute clinical manifestations. With this programme the microfilaria rate by finger prick decreased from 24% to 0%, and by Nuclepore filtration from 30% to 5%. The adenolymphangitis rate decreased from 46% to 11% and the "elephantiasis' rate from 17% to 4%.
AuthorsF Partono, Purnomo, S Oemijati, A Soewarta
JournalActa tropica (Acta Trop) Vol. 38 Issue 3 Pg. 217-25 (Sep 1981) ISSN: 0001-706X [Print] Netherlands
PMID6118029 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.)
Chemical References
  • Diethylcarbamazine
Topics
  • Adolescent
  • Adult
  • Aged
  • Animals
  • Blood (parasitology)
  • Brugia
  • Child
  • Child, Preschool
  • Diethylcarbamazine (administration & dosage, therapeutic use)
  • Elephantiasis (drug therapy)
  • Female
  • Filariasis (drug therapy, prevention & control)
  • Humans
  • Indonesia
  • Infant
  • Infant, Newborn
  • Lymphedema (drug therapy)
  • Male
  • Microfilariae
  • Middle Aged
  • Rural Population

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: